Biofil Chemicals announces trading window closure from July 1, 2026

Biofil Chemicals & Pharmaceuticals has informed the stock exchanges that the trading window for its securities will be closed from Wednesday, July 1, 2026, for all designated persons, their immediate relatives and connected persons. The closure is in line with SEBI insider trading regulations and is in place for the consideration of unaudited financial results for the quarter ended June 30, 2026. The trading window will reopen 48 hours after these results are declared to the exchanges. The date of the board meeting to approve the Q1 results will be announced later. This is a routine compliance filing and does not involve any corporate action.